Aim Haglund's syndrome may be responsible for chronic pain in the ankle and hindfoot. Although numerous therapeutic approaches have been described in the literature, to this date no consensus over a surgical treatment has been established. We report our experience in the treatment of Haglund's syndrome and pre-insertional calcifications of the Achilles tendon using an open surgical approach and platelet rich plasma (PRP) membranes as a local adjuvant. Methods The study retrospectively evaluated patients with Haglund syndrome treated with a direct posterior access, Achilles tendon split, bursectomy, resection of the heel deformity and topical administration of PRP membranes. After surgery, a standardized rehabilitation protocol was performed. The preoperative and postoperative functionalities of the foot and ankle were assessed using the American Orthopaedic Foot & Ankle Society (AOFAS) score. Intraoperative and postoperative complications were recorded. Results Twenty consecutive patients were included. The mean follow-up was 23 months. No patient had major intraoperative or postoperative complications. After the surgery, the mean AOFAS score increased from 44.1 to 92.0, resulting in a statistically significant increase in patient functionality after the treatment (p=0.001). Conclusion Our results suggest that an open surgical approach consisting of a combination of bursectomy, resection of the calcaneal deformity, and topical administration of PRP membranes may be effective for the treatment of Haglund's disease.
Chatterton BD, Muller S, Roddy E. Epidemiology of posterior heel pain in the general population: crosssectional findings from the clinical assessment study of the foot. Arthritis Care Res (Hoboken. 2015;67:996–1003.
2.
Vega MR, Cavolo DJ, Green RM, Cohen RS. Haglund’s deformity. J Am Podiatry Assoc. 1984;74:129–35.
Vaishya R, Agarwal AK, Azizi AT, Vijay V. Haglund’s Syndrome: A Commonly Seen Mysterious Condition. Cureus. 2016;8:e820.
5.
Pavlov H, Heneghan MA, Hersh A, Goldman AB, Vigorita V. The Haglund syndrome: initial and differential diagnosis. Radiology. 1982;144:83–8.
6.
Zhou S, Luo W, Wang S, Zhang K. 12 Cases of Haglund’s syndrome detected through MRI Curr Med Imaging. Vol. 19. 2023. p. 1079–83.
7.
Yuen WLP, Tan PT, Kon KKC. Surgical Treatment of Haglund’s Deformity: A. Systematic Review and Meta-Analysis Cureus. 2022;14:e27500.
8.
Stephens MM. Haglund’s deformity and retrocalcaneal bursitis. Orthop Clin North Am. 1994;25 41-6.
9.
Heneghan MA, Pavlov H. The Haglund painful heel syndrome. Experimental investigation of cause and therapeutic implications. Clin Orthop Relat Res. 1984;187:228–34.
10.
Watson AD, Anderson RB, Davis WH. Comparison of results of retrocalcaneal decompression for retrocalcaneal bursitis and insertional Achilles tendinosis with calcific spur. Foot Ankle Int. 2000;21:638–42.
11.
Kandemir V, Akar MS, Yiğit Ş, Durgut F, Atiç R, Özkul E. Can American Orthopaedic Foot and Ankle Society (AOFAS) score prevent unnecessary MRI in isolated ankle ligament injuries? J Orthop Surg (Hong Kong. 2022;30(10225536221131374).
12.
Clavien PA, Barkun J, Oliveira ML. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(187):196.
13.
Robinson JM, Cook JL, Purdam C. The VISAA questionnaire: a valid and reliable index of the clinical severity of Achilles tendinopathy. Br J Sports Med. 2001;35:335–41.
14.
Hallaçeli H, Uruç V, Uysal HH. Normal hip, knee and ankle range of motion in the Turkish population. Acta Orthop Traumatol Turc. 2014;48:37–42.
15.
Dijk CN, Dyk GE, PE S, NP K. Endoscopic calcaneoplasty. Am J Sports Med. 2001;29:185–9.
16.
Anderson JA, Suero E, O’Loughlin PF, Kennedy JG. Surgery for retrocalcaneal bursitis: a tendonsplitting versus a lateral approach. Clin Orthop Relat Res. 2008;466:1678–82.
17.
Xia Z, Yew AKS, Zhang TK, Su HCD, Ng YCS, Rikhraj IS. Surgical correction of Haglund’s triad using a central tendon-splitting approach: a retrospective outcomes study. J Foot Ankle Surg. 2017;56:1132–8.
18.
Yurdakul E, Kizilci H. Léčba Haglundovy trias z přístupu s využitím centrálního protnutí šlachy: spokojenost pacienta a chirurgické výsledky (Haglund’s triad treatment using a central tendon-splitting approach: patient satisfaction and surgical outcomes. Czech] Acta Chir Orthop Traumatol Cech. 2021;88:284–90.
19.
McGarvey WC, Palumbo RC, Baxter DE, Leibman BD. Insertional Achilles tendinosis: surgical treatment through a central tendon splitting approach. Foot Ankle Int. 2002;23:19–25.
20.
Güler Y, Birinci M, Hakyemez ÖS, Buyukdogan K, Çaçan MA, Arslanoglu F, et al. Achilles tendon-splitting approach and double-row suture anchor repair for Haglund syndrome. Foot Ankle Surg. 2021;27:421–6.
21.
Simpson MR, Howard TM. Tendinopathies of the foot and ankle. Am Fam Physician. 2009;80:1107–14.
22.
Ciapini G, Simonettii M, Giuntoli M, Varchetta G, Franco S, Ipponi E, et al. Is the combination of platelet-rich plasma and hyaluronic acid the best injective treatment for grade II-III knee osteoarthritis? A prospective study. Adv Orthop. 2023;2023(1868943).
23.
Wang JH. Can PRP effectively treat injured tendons? Muscles Ligaments Tendons J. 2014;4:35–7.
24.
Padilla S, Sánchez M, Vaquerizo V, Malanga GA, Fiz N, Azofra J, et al. Platelet-rich plasma applications for achilles tendon repair: a bridge between biology and surgery. Int J Mol Sci. 2021;22(824).
25.
Dietrich F, Duré L, G PK, C FB, V VP, A DS, et al. Platelet-rich fibrin promotes an accelerated healing of achilles tendon when compared to platelet-rich plasma in rat. World J Plast Surg. 2015;4:101–9.
26.
Zhou Y, Wang JH. PRP Treatment efficacy for tendinopathy: a review of basic science studies. Biomed Res Int. 2016;2016(9103792).
27.
Yu TY, Pang JS, Lin LP, Cheng JW, Liu SJ, Tsai WC. Platelet-rich plasma releasate promotes early healing in tendon after acute injury. Orthop J Sports Med. 2021;9(2325967121990377).
28.
Rollo G, Bonura EM, Falzarano G, Bisaccia M, Ribes Iborra J, Grubor P, et al. Platet rich plasma or hyperbaric oxygen therapy as callus accellerator in aseptic tibial non union. Evaluate of outcomes Acta Biomed. 2020;91:e2020188.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
